Synthesis, Molecular Mechanism and Pharmacokinetic Studies of New Epoxy Lignan ‐Based Derivatives
The oxidative demethylation procedure for a new epoxy lignan isolated from Piper nigrum was applied to the synthesis of 3’‐methoxy‐3”,4”‐(methylenedioxy)‐2,5‐epoxylignan‐4’‐ol‐6’‐one. This compound inhibited the mRNA expression of the protein patched homolog (Ptch) in human pancreatic cancer cells (PANC1) and therefore might be valuable as a probe for tumor‐related disease. The pharmacokinetic profile of 3'‐methoxy‐3”,4”‐(methylenedioxy)‐2,5‐epoxylignan‐4'‐ol‐6'‐one was rapidly determined using ultra‐fast liquid chromatography. The compound was rapidly absorbed in blood.
3′‐Methoxy‐3″,4″‐(methylenedioxy)‐2,5‐epoxylignan‐4′‐ol‐6′‐one was derived from a new epoxy lignan isolated from Piper nigrum. The pharmacokinetic profile of this compound was determined using ultra‐fast liquid chromatography.
Source: Archiv der Pharmazie - Category: Drugs & Pharmacology Authors: Yusnita Rifai, Harold B. Tani, Muhammad Nur, Muhammad Aswad, Subehan Lallo, Elly Wahyudin Tags: Full Paper Source Type: research
More News: Black Pepper | Cancer | Cancer & Oncology | Drugs & Pharmacology | Pancreas | Pancreatic Cancer | Study